Trepharm
Trepharm is a Kosovo-based pharmaceutical manufacturer producing generic OTC and prescription medications at an EU cGMP-certified facility, supplying over 80% of domestic pharmacies and exporting to Asian markets with Balkan and European expansion in preparation.
- Company typePrivate
- Founded2008
- HeadquartersKosova, Albania
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Trepharm does
Trepharm Sh.P.K. is a Kosovo-based pharmaceutical manufacturer and the first drug producer in the country operating from a facility built to EU cGMP standards. The company manufactures a portfolio of more than 120 generic pharmaceutical products spanning over-the-counter (OTC) and prescription (RX) categories, operating a B2B model that supplies finished dosage forms to pharmacy distributors, retail pharmacies, and institutional buyers. Trepharm is family-owned, part of the Tregtia group associated with the Bedri Prishtina family.
The company operates from a purpose-built manufacturing facility representing approximately 15 million EUR of invested capital, with a workforce of more than 250 employees. The site holds EU cGMP, WHO, and ISO certifications, and is equipped with building management systems (BMS), HVAC controls, and purified water infrastructure consistent with regulated pharmaceutical production. Trepharm supplies more than 80% of pharmacies in Kosovo and has begun exporting into Asian markets, with stated preparations for broader Balkan and European expansion. The company is additionally developing a sterile injectable manufacturing unit to extend its product range beyond oral solid dosage forms.
Trepharm's commercial model centers on generic drug production for a small domestic market, with revenue derived from unit sales across a broad product portfolio rather than concentrated contracts with individual large buyers. Notable institutional relationships include supply to Kosovo's Ministry of Health and training engagement with the American Embassy in Kosovo. The company has pursued international growth through partnerships with CIPEX (USA), ECIKS, and the UK Government, including trade envoy engagement in February 2022. Pricing follows generic-sector dynamics, with margins dependent on regulatory approval costs, certification barriers, and the cost advantage of domestic manufacturing relative to imported generics.
Trepharm firmographics
Firmographics- Name
- Trepharm
- Legal name
- Trepharm Sh.P.K.
- Website
- https://trepharm.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Trepharm is a Kosovo-based pharmaceutical manufacturer producing generic OTC and prescription medications at an EU cGMP-certified facility, supplying over 80% of domestic pharmacies and exporting to Asian markets with Balkan and European expansion in preparation.
- Ownership category
- akta.pro rank
Trepharm industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industry
- OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)
Keywords
Where Trepharm is headquartered
LocationHeadquarters
- HQ city
- Kosova
- HQ country
- Albania
- HQ region
- Europe
Offices1 record
Markets served
Trepharm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Manufacturing & Sales: Trepharm generates revenue through manufacturing and selling high-quality generic pharmaceutical products including OTC and prescription medications. Products are distributed to pharmacies and healthcare providers domestically and through exports to international markets.
- Contract Manufacturing: The company appears to engage in contract manufacturing partnerships, as indicated by cooperation with CIPEX USA and technological support from European companies.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Trepharm product offering
Product offeringCore offering
Trepharm is a pharmaceutical manufacturer producing a portfolio of generic OTC (Over-The-Counter) and RX (Prescription) medications across dosage forms including tablets, capsules, syrups, suspensions, granules, and topical gels. The company manufactures over 120 approved pharmaceutical products spanning therapeutic areas such as cardiovascular, anti-infective, neurological, metabolic, respiratory, and gastrointestinal conditions at an EU cGMP-certified facility in Kosovo. Products are sold primarily to pharmacies, healthcare providers, and government institutions domestically and exported to Balkan and Asian markets.
Product overview
Trepharm operates as a pharmaceutical manufacturer offering two distinct product lines: OTC (Over-The-Counter) and RX (Prescription) medications. The company produces comprehensive pharmaceutical solutions across multiple dosage forms including tablets, capsules, powders, liquids, creams, and gels. Their RX product portfolio covers therapeutic areas such as cardiovascular conditions (ASTAT, AMLODIPINE, LISOCARD, LOCARD, VALSACARD, TRIOCARD), anti-infectives (AZITRE, BACTRE, CEF, CEFEXEL, CIPROT, ERYTRE, TRECLOR, TREKLIN), neurological/psychiatric (DIAZEPAM, EXPERGO, XALAM), metabolic disorders (PRIMET, GLIMUR, SECUMET, SECUVIA, HCTZ), respiratory (AMINOPHYLLINE, SALBUTAMOL), urological (TREAGRA), and gastrointestinal (PROTOPEN, LOPERAMIDE, NIFUREX, FUNGIZOL). Their OTC line includes pain/fever relievers (DOLOFIX, ALBADOL, DICLOFEN), antihistamines (LORATADINE), respiratory aids (ACT), cardiovascular (ASPIRIDOL PROTECT), and topical treatments (PROGEL). All products are manufactured under strict GMP and ISO standards at their EU-GMP certified facility in Kosovo.
Differentiator
Problem solved
Functional benefit
Products and services
- RX Products (Prescription Medications) Prescription pharmaceutical products for treating complex health conditions including cardiovascular, anti-infective, neurological, metabolic, and respiratory diseases. Products include tablets, capsules, granules for oral suspension, and syrups, sold to pharmacies and healthcare providers under EU cGMP quality standards.
- OTC Products (Over-The-Counter Medications) Over-the-counter medications for everyday health needs including pain relief, cold remedies, allergy care, and digestive support. Includes products in tablets, capsules, syrups, suspensions, and topical gels, sold through pharmacies and healthcare providers.
- Research & Development Services In-house R&D division pioneering pharmaceutical innovations and formulation breakthroughs, with focus areas in oncology and infectious diseases, supporting the development of over 30 pharmaceutical formulations.
- Quality Control Laboratory Services Advanced analytical testing laboratory for product efficacy, purity, and safety testing, constructed to GLP standards and equipped to serve as a reference laboratory for the region, including for Ministry of Health measurements.
Quantifiable outcome
- Supplying over 80% of pharmacies in Kosovo
- +2 more outcomes
Companies that use Trepharm
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Trepharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Trepharm partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered support and core.
- UK Government / UK UniversitiessupportSupport from UK Government including links with UK Universities, training of Trepharm staff, and cooperation with UK businesses engaged in Pharmaceuticals. Discussions included mutual trade and commerce links between UK and Kosovo.
- CIPEX USAcoreCooperation with American company CIPEX USA for technological support and pharmaceutical manufacturing expertise. This partnership helped establish Trepharm as one of the only drug manufacturers in the region implementing European quality and safety standards (EU cGMP and WHO standards).
- Kieback&Peter (Germany)coreGerman technology partner providing Building Management System (BMS) for the facility. The BMS continuously monitors and records environmental conditions including temperature and humidity, offering real-time alerting for deviations from predefined thresholds.
- GEA Klimatechnik GmbH & Co. KG (Austria)coreAustrian manufacturer providing all HVAC (Heating, Ventilation, and Air Conditioning) units for the facility. The system uses gas heating and water-based chillers for cooling with fully automated air recirculation, filtration, and cleaning to prevent cross-contamination and environmental pollution.
- ECIKS (Kosovo Business Foundation)supportPartnership with ECIKS for pursuing further expansion opportunities and international collaborations. ECIKS supports Trepharm's growth initiatives and market expansion strategies.
Scale indicators6 records
Recent moves7 records
Expansion highlights4 records
Trepharm competitors and assessment
Company assessmentDirect peers
- Bosnalijek: Bosnia and Herzegovina-based pharmaceutical manufacturer of generic Rx and OTC products. Direct comparable on geography, customer base (pharmacy channel), and product mix (broad therapeutic-area generics in tablets, capsules, and liquids).
- Hemofarm: Serbian generic pharmaceutical manufacturer (STADA group) with a broad OTC/RX portfolio and Balkan-centric footprint. Directly comparable to Trepharm as a regional generic producer serving domestic pharmacy chains and exporting to neighboring markets.
- Krka: Slovenia-based generic pharmaceutical manufacturer with a broad portfolio across CEE, Balkans, and Western Europe. Krka is the closest scale and geographic analogue to Trepharm's ambitions — a regional generic producer expanding from a smaller home market into the EU.
- Galenika: Serbian generic pharmaceutical manufacturer with a portfolio of Rx and OTC products across multiple therapeutic categories. Comparable as a Balkan-headquartered generic producer serving the regional pharmacy channel with similar dosage-form capabilities.
- Zentiva: Pan-European generic pharmaceutical manufacturer with strong CEE and Balkan presence, producing tablets, capsules, and other dosage forms. Zentiva is a relevant benchmark for Trepharm's target positioning as an EU-cGMP generic supplier across multiple therapeutic areas.
Emerging players
- Cipla: India-based global generic pharmaceutical manufacturer exporting to emerging markets including Africa and parts of Asia. Comparable as a low-cost generic exporter competing on price-quality in the same international markets where Trepharm is already present.
Broad incumbents
- Alvogen: Global generic pharmaceutical company with established CEE and Balkans commercial operations. Relevant as a larger incumbent that Trepharm would compete against in regional tender and pharmacy-channel opportunities.
- STADA Arzneimittel: European-headquartered generic and consumer healthcare company with a strong Balkans footprint (via Hemofarm). Comparable as a broader incumbent whose portfolio and pricing power Trepharm would face in cross-border expansion.
- Novartis (Sandoz division): Global generic pharmaceutical leader (Sandoz) competing in the same EU tender and pharmacy-channel markets Trepharm is targeting. Relevant as the scale benchmark for what 'EU-cGMP generic manufacturer' looks like at full size.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer, with a presence across all major therapeutic categories and geographies. Represents the ceiling case for what Trepharm could scale into, and the dominant competitive force in European generic tenders.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Trepharm social profiles
Digital presenceTrepharm compliance and trust
Trust signalCompliance7 records
Trepharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trepharm leadership team
Management profileNumber of profiles
Profiles13 records
Trepharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trepharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trepharm
What does Trepharm do?
Trepharm is a pharmaceutical manufacturer producing a portfolio of generic OTC (Over-The-Counter) and RX (Prescription) medications across dosage forms including tablets, capsules, syrups, suspensions, granules, and topical gels. The company manufactures over 120 approved pharmaceutical products spanning therapeutic areas such as cardiovascular, anti-infective, neurological, metabolic, respiratory, and gastrointestinal conditions at an EU cGMP-certified facility in Kosovo. Products are sold primarily to pharmacies, healthcare providers, and government institutions domestically and exported to Balkan and Asian markets.
Is Trepharm a public or private company?
Trepharm is a private company. It is classified as family owned and is currently operating.
When was Trepharm founded?
Trepharm was founded in 2008. It employs 101 to 250 people.
Where is Trepharm based?
Trepharm is headquartered in Kosova, Albania, in the Europe region.
How does Trepharm make money?
Two revenue lines are on record. Pharmaceutical Manufacturing & Sales are the primary driver. The others are contract Manufacturing.
Who are Trepharm's main competitors?
Direct peers on record are Bosnalijek, Hemofarm, Krka, Galenika and Zentiva. Cipla is listed as an emerging player. Broad incumbents are Alvogen, STADA Arzneimittel, Novartis (Sandoz division) and Teva Pharmaceutical Industries.
Does Trepharm have an API?
No public API is recorded for Trepharm.
What industry is Trepharm in?
Trepharm's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief). Its NAICS code is 325412 and its SIC code is 2834.